Ultima-Stan 10 Mg 50 Tablets Ultima Pharma INT
$45.00
Product Short Description
Ultima-Stan 10 mg 50 Tablets Ultima Pharma INT delivers stanozolol (C21H32N2O), the pyrazole-fused DHT anabolic steroid exhibiting high anabolic potency (~320:30 ratio), at controlled oral 10 mg strength matching institutional performance specifications. International production serves global performance markets through verified distribution channels.
Product Overview
Ultima Pharma INT’s Stan 10 mg presents stanozolol, featuring C2-C3 pyrazole substitution preventing aromatization characteristic of 17α-methylated DHT derivatives (~8-hour half-life), in USP-equivalent scored tablets for international institutional catalogs. The 50-tablet tamper-evident configuration supports controlled inventory management across encrypted global specialist platforms requiring batch traceability.
International manufacturing provides worldwide fulfillment while maintaining pharmaceutical-grade specifications distinguishing legitimate Schedule III-equivalent supply from underground tablet presses prevalent in non-verified markets. Conservative 10 mg dosage serves advanced international resellers managing controlled substance inventories prioritizing safety margins.
Ultima-Stan INT targets verified international performance ecosystems emphasizing commercial positioning without protocols or claims.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Ultima-Stan 10 mg 50 Tablets Ultima Pharma INT |
| Active Compound | Stanozolol (C21H32N2O) |
| Strength | 10 mg per scored tablet |
| Quantity | 50 tablets per bottle |
| Form | Oral scored tablets |
| Category | Anabolic steroid (controlled substance jurisdiction-dependent) |
| Packaging | Tamper-evident HDPE bottle |
| Label Elements | 10 mg declaration, batch code, international warnings |
Quality Control & Testing Standards
10 mg stanozolol mandates HPLC potency assay (90-110%), dissolution profiling, and uniformity verification confirming pharmaceutical-grade content. Ultima INT batch documentation verifies C21H32N2O identity distinguishing legitimate production from underground alternatives.
50-tablet institutional bottling prevents diversion matching international pharmaceutical protocols.
Legal & Regulatory Disclaimer
Stanozolol constitutes controlled substance status varying by jurisdiction (DEA Schedule III in U.S., equivalent classifications globally); non-medical handling subject to local Controlled Substances legislation. Buyer assumes complete international regulatory compliance; zero medical claims provided.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Reviews
There are no reviews yet.